• Megumi Koizumi, Miho Ishimaru, Hiroki Matsui, Kiyohide Fushimi, Tatsuya Yamasoba, and Hideo Yasunaga.
• Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 1130033, Japan. imegumi-zao@umin.ac.jp.
• Eur Arch Otorhinolaryngol. 2019 Jan 1; 276 (1): 249-254.

PurposeAlthough post-tonsillectomy hemorrhage occurs rarely, it can be life-threatening. Previous studies showed that tranexamic acid (TXA) had insignificant association with the rate of post-tonsillectomy hemorrhage, but those findings were limited by small sample sizes. The purpose of this study was to examine the effectiveness of TXA in preventing post-tonsillectomy hemorrhage using nationwide database.MethodsData of a retrospective cohort of 117,598 patients from 750 hospitals, who had undergone tonsillectomy between 2010 and 2016, were drawn from the Diagnosis Procedure Combination database in Japan and studied.ResultsPropensity score-matched analysis showed no significant differences in proportions of reoperation or blood transfusion after tonsillectomy between the treatment (TXA from the day of tonsillectomy) and control groups (1.50% vs. 1.47%, p = 0.64). Instrumental variable analysis also showed no significant differences (odds ratio, 0.98; 95% confidence interval, 0.86-1.13; p = 0.82). Higher proportions of reoperation or blood transfusion were significantly associated with male sex, older age, emergency hospitalization, prolonged anesthesia, and medium hospital volume (annual number of tonsillectomies).ConclusionsAdministration of TXA from the day of tonsillectomy is not associated with reduction in reoperation or blood transfusion rates.

29 keywords...

hide…